Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM 2020-12-18 15:34
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals 2020-12-18 06:52
dMed Completed a US$100 Million Series C Financing 2020-12-17 13:00
Global UV Cured Resins Market will grow to US$ 7892.70 Mn by 2028 at 8.9% CAGR - says Absolute Markets Insights 2020-12-17 11:00
Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange 2020-12-17 08:19
Covance, LabCorp's Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials 2020-12-17 00:29
EpiVax Reports Record Year for Immunogenicity Screening Toolkit (ISPRI) 2020-12-16 02:15
RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model 2020-12-16 00:42
Clarity Pharmaceuticals closes $25m capital raising 2020-12-15 22:12
ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures 2020-12-15 22:00
PCCS Group Has Reached a Strategic Cooperation With Shenqi Medical to Seek a Grand Blueprint of Medical Health in the Asia-pacific Region 2020-12-15 18:30
GMAX Zhengzhou Manufacturing Site Breaks Ground 2020-12-15 18:00
Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials 2020-12-15 08:00
Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration 2020-12-14 22:28
I-Mab Added to Nasdaq Biotechnology Index 2020-12-14 21:00
Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration 2020-12-14 20:20
The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention 2020-12-14 09:00
Gannex Received U.S. FDA Fast Track Designation for Its NASH Drug Candidate ASC42，an FXR Agonist 2020-12-14 08:30
Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates 2020-12-12 11:02
BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 2020-12-11 21:00
1 266 267 268 269 270 412